Article
A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
EMBO molecular medicine - 1 Jan 2018
Umoh Mfon E, Dammer Eric B, Dai Jingting, Duong Duc M, Lah James J, Levey Allan I, Gearing Marla, Glass Jonathan D, Seyfried Nicholas T
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases with overlap in clinical presentation, neuropathology, and genetic underpinnings. The molecular basis for the overlap of these disorders is not well established. We performed a comparative unbiased mass spectrometry-based proteomic analysis of frontal cortical tissues from postmortem cases clinically defined as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
